Landau Jeffrey B
SEC CIK 1918615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | Chief Business Off | 123.2K | — | $38.7K | 12 | 2022-07-19 | 2024-08-20 |
Most active insiders at CTMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Sean A. | CEO, Dir | — | $1.23M |
| 2 | BELVIN MARCIA | SVP, CSO | — | $202.2K |
| 3 | Chu Yu-Waye | Chief Medical Off | — | $136.6K |
| 4 | Ogden Christopher | CFO | — | $129.0K |
| 5 | Lester Rachael | Chief Business Off | — | — |
| 6 | Carvajal Alejandra | CLO | — | — |
Landau Jeffrey B made no open-market trades at CTMX in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | M - OptEx | $0.00 | +11.2K | 123.2K | +10% | $0 |
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | S - Sale+OE | $1.23 | -4,181 | 119.1K | -3% | -$5,143 |
| 2024-03-21 | 2024-03-19 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | S - Sale | $2.09 | -6,562 | 110.1K | -6% | -$13.7K | |
| D | 2024-01-19 | 2024-01-18 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | A - Grant | $0.00 | +30.0K | 116.6K | +35% | $0 |
| 2023-12-22 | 2023-12-20 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | S - Sale | $1.38 | -4,077 | 86.6K | -4% | -$5,626 | |
| D | 2023-12-19 | 2023-12-17 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | M - OptEx | $0.00 | +11.2K | 90.7K | +14% | $0 |
| 2023-09-22 | 2023-09-20 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | A - Grant | $0.00 | +11.2K | 80.5K | +16% | $0 | |
| 2023-09-22 | 2023-09-22 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | S - Sale | $1.30 | -4,119 | 76.4K | -5% | -$5,355 | |
| 2023-03-20 | 2023-03-16 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | CFO | S - Sale | $1.98 | -1,477 | 69.2K | -2% | -$2,924 | |
| D | 2023-02-06 | 2023-02-02 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | A - Grant | $0.00 | +40.0K | 70.7K | +130% | $0 |
| 2022-07-21 | 2022-07-19 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | A - Grant | $0.00 | +11.2K | 34.9K | +48% | $0 | |
| 2022-07-21 | 2022-07-20 | CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Off | S - Sale | $1.42 | -4,206 | 30.7K | -12% | -$5,973 |
Purchase Sale Sale after option exercise All abbreviations